Long-term cognitive dysfunction after radiation therapy for primary brain tumors

References

• Saad S, Wang TJC. Neurocognitive deficits after radiation therapy for brain malignancies. Am J Clin Oncol. 2015;38:634–640.
   PubMed Web of Science ®Google Scholar
• Hahn CA, Zhou S-M, Raynor R, et al. Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction. Int J Radiat Oncol Biol Phys. 2009. DOI:10.1016/j.ijrobp.2008.05.061
   Web of Science ®Google Scholar
• van Kessel E, Baumfalk AE, van Zandvoort MJE, et al. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment. J Neurooncol. 2017. DOI:10.1007/s11060-017-2503-z
   PubMed Web of Science ®Google Scholar
• Ali FS, Hussain MR, Gutiérrez C, et al. Cognitive disability in adult patients with brain tumors. Cancer Treat Rev. 2018. DOI:10.1016/j.ctrv.2018.02.007
   Web of Science ®Google Scholar
• Pinkham MB, Bertrand KC, Olson S, et al. Clinical study hippocampal-sparing radiotherapy: the new standard of care for World Health Organization grade II and III gliomas? 2014. DOI:10.1016/j.jocn.2013.04.005
   Google Scholar
• Hendrix P, Hans E, Griessenauer CJ, et al. Neurocognitive function surrounding the resection of frontal WHO grade I meningiomas: a prospective matched-control study. World Neurosurg. 2017. DOI:10.1016/j.wneu.2016.10.095
   Web of Science ®Google Scholar
• McAleer MF, Brown PD. Neurocognitive function following therapy for low-grade gliomas. Semin Radiat Oncol. 2015. DOI:10.1016/j.semradonc.2015.02.005
   PubMed Web of Science ®Google Scholar
• Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002. DOI:10.1016/S0140-6736(02)11398-5
   Web of Science ®Google Scholar
• Gondi V, Hermann BP, Mehta MP, et al. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol. 2013;85:348–354.
   PubMed Web of Science ®Google Scholar
• Tsai P-F, Yang C-C, Chuang C-C, et al. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study. Radiat Oncol. 2015;10. DOI:10.1186/s13014-015-0562-x
   Web of Science ®Google Scholar
• Gondi V, Tomé WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother Oncol. 2010;97:370–376.
   PubMed Web of Science ®Google Scholar
• Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. JCO. 2014;32:3810–3816.
   PubMed Web of Science ®Google Scholar
• Jaspers J. 14 – The hippocampal NTCP model could not be validated within the EORTC-22033 low-grade glioma trial. 2018;20–21.
   Google Scholar
• Benedict RHB, Schretlen D, Groninger L, et al. Hopkins verbal learning test? Revised: normative data and analysis of inter-form and test–retest reliability. Clin Neuropsychol (Neuropsychol, Dev Cogn Sect D). 1998. DOI:10.1076/clin.12.1.43.1726
   Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–820.
   PubMed Web of Science ®Google Scholar
• Reitan R. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958. DOI:10.2466/PMS.8.7.271-276
   Google Scholar
• Thurstone LL. Primary mental abilities. Science. 1948;108:2813.
   Web of Science ®Google Scholar
• Wechsler D. Wechsler adult intelligence scale – fourth edition (WAIS-IV). San Antonio; 2008.
   Google Scholar
• Wiens AN, Fuller KH, Crossen JR. Paced auditory serial addition test: adult norms and moderator variables. J Clin Exp Neuropsychol. 1997. DOI:10.1080/01688639708403737
   PubMed Web of Science ®Google Scholar
• Stroop JR. Stroop color word test. J Exp Physiol. 1935. DOI:10.1007/978-0-387-79948-3
   Google Scholar
• Chelune GJ, Heaton RK, Lehman RAW. Neuropsychological and personality correlates of patients’ complaints of disability. 1986. DOI:10.1007/978-1-4613-2211-5_4
   Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993. DOI:10.1093/jnci/85.5.365
   PubMedGoogle Scholar
• Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989. DOI:10.1016/0165-1781(89)90047-4
   PubMed Web of Science ®Google Scholar
• Tennant KF, Takacs SE, Gau J-T, et al. A preliminary study of symptomatic fatigue in rural older adults. Aging Clin Exp Res. 2012. DOI:10.3275/8054
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983. DOI:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983. DOI:10.2307/2136404
   PubMed Web of Science ®Google Scholar
• Wefel JS, Vardy J, Ahles T, et al. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12:703–708.
   PubMed Web of Science ®Google Scholar
• Hutchinson AD, Hosking JR, Kichenadasse G, et al. Complications of treatment objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38:926–934.
   PubMed Web of Science ®Google Scholar
• Gehring K, Sitskoorn MM, Aaronson NK, et al. Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol. 2008. DOI:10.1016/S1474-4422(08)70111-X
   PubMed Web of Science ®Google Scholar
• Loon E, Heijenbrok-Kal M, Loon W, et al. Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: a systematic review. J Rehabil Med. 2015;47:481–488.
   PubMed Web of Science ®Google Scholar
• Douw L, Klein M, Fagel SSAA, et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. 2009;8. DOI:10.1016/S1474
   Google Scholar
• Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 1994. DOI:10.1002/ana.410360111
   PubMed Web of Science ®Google Scholar
• Brummelman P, Sattler MGA, Meiners LC, et al. Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex. Eur J Endocrinol. 2012. DOI:10.1530/EJE-11-07496
   PubMed Web of Science ®Google Scholar
• Fortsat fald antidepressiv medicin 2016 – Sundhedsdatastyrelsen. Available from: https://sundhedsdatastyrelsen.dk/da/nyheder/2017/medicinforbrug-indblik-antidepressiver_04072017
   Google Scholar